Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trial
- 31 May 1995
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 21 (1) , 37-42
- https://doi.org/10.1016/0920-1211(95)00006-v
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake ratsEuropean Journal of Pharmacology, 1992
- Randomizing respondersControlled Clinical Trials, 1991
- Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitorEuropean Journal of Pharmacology, 1991
- (R)‐N‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake CarrierJournal of Neurochemistry, 1990
- A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Sodium Valproate, Serum Level and Clinical Effect in Epilepsy: A Controlled StudyEpilepsia, 1979
- Controlled trial of sodium valproate in severe epilepsy.BMJ, 1975
- 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over DesignPublished by JSTOR ,1972